Free Trial

Best Stocks Under $10 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $10.00 (10 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Birchcliff Energy stock logo

1. Birchcliff Energy OTCMKTS:BIREF

$4.16 +0.10 (+2.46%)
As of 04/14/2025 03:43 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.13 billion
P/E Ratio
29.71
Consensus Rating
Strong Buy
Volume
6,897 shares
Average Volume
114,181 shares
Today's Range
$4.05
$4.16
Glencore stock logo

2. Glencore OTCMKTS:GLNCY

$6.84 +0.02 (+0.29%)
As of 04/14/2025 04:00 PM Eastern

Glencore plc engages in the production, refinement, processing, storage, transport, and marketing of metals and minerals, and energy products in the Americas, Europe, Asia, Africa, and Oceania. More about Glencore

Market Capitalization
$41.28 billion
Consensus Rating
Strong Buy
Volume
2.61 million shares
Average Volume
1.21 million shares
Today's Range
$6.75
$6.90
50-Day Range
$5.84
$8.86
Serve Robotics stock logo

3. Serve Robotics NASDAQ:SERV

$5.78 -0.01 (-0.09%)
As of 09:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Serve Robotics Inc designs, develops, and operates low-emission robots that serve people in public spaces with food delivery in the United States. More about Serve Robotics

Market Capitalization
$329.10 million
P/E Ratio
-4.82
Consensus Rating
Strong Buy
Consensus Price Target
$19.50 (+237.1% Upside)
Volume
101,295 shares
Average Volume
9.26 million shares
Green Thumb Industries stock logo

4. Green Thumb Industries OTCMKTS:GTBIF

$5.07 +0.03 (+0.60%)
As of 04/14/2025 03:59 PM Eastern

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. More about Green Thumb Industries

Market Capitalization
$1.08 billion
P/E Ratio
21.13
Consensus Rating
Strong Buy
Consensus Price Target
$16.50 (+225.4% Upside)
Volume
300,358 shares
Average Volume
483,205 shares
NexGen Energy stock logo

5. NexGen Energy NYSE:NXE

$4.62 +0.01 (+0.11%)
As of 09:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NexGen Energy Ltd., an exploration and development stage company, engages in the acquisition, exploration, and evaluation and development of uranium properties in Canada. More about NexGen Energy

Market Capitalization
$2.63 billion
P/E Ratio
30.84
Consensus Rating
Strong Buy
Volume
11,492 shares
Average Volume
9.94 million shares
Today's Range
$4.63
$4.63
Stardust Power stock logo

6. Stardust Power NASDAQ:SDST

$0.64 0.00 (-0.39%)
As of 09:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$36.76 million
Consensus Rating
Buy
Consensus Price Target
$5.11 (+705.1% Upside)
Volume
1,484 shares
Average Volume
353,185 shares
Today's Range
$0.62
$0.62
Remove Ads
OnKure Therapeutics stock logo

7. OnKure Therapeutics NASDAQ:OKUR

$3.11 +0.07 (+2.34%)
As of 09:40 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$41.80 million
P/E Ratio
-0.26
Consensus Rating
Buy
Consensus Price Target
$32.33 (+939.3% Upside)
Volume
110 shares
Average Volume
69,547 shares
Achieve Life Sciences stock logo

8. Achieve Life Sciences NASDAQ:ACHV

$2.19 +0.02 (+0.69%)
As of 09:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. More about Achieve Life Sciences

Market Capitalization
$76.48 million
P/E Ratio
-1.95
Consensus Rating
Buy
Consensus Price Target
$15.75 (+617.5% Upside)
Volume
97,460 shares
Average Volume
180,346 shares
Maze Therapeutics stock logo

9. Maze Therapeutics NASDAQ:MAZE

$8.50 +0.67 (+8.56%)
As of 04/14/2025 04:00 PM Eastern

We are a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. More about Maze Therapeutics

Market Capitalization
$372.27 million
Consensus Rating
Buy
Consensus Price Target
$25.67 (+202.0% Upside)
Volume
124,495 shares
Average Volume
296,972 shares
Today's Range
$7.90
$8.87
OS Therapies stock logo

10. OS Therapies NYSE:OSTX

$1.36 +0.11 (+8.40%)
As of 09:42 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$29.03 million
Consensus Rating
Buy
Consensus Price Target
$18.00 (+1,228.4% Upside)
Volume
103,829 shares
Average Volume
494,093 shares
Today's Range
$1.27
$1.39
Coeur Mining stock logo

11. Coeur Mining NYSE:CDE

$6.09 +0.02 (+0.28%)
As of 09:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Coeur Mining, Inc explores for precious metals in the United States, Canada, and Mexico. The company primarily explores for gold, silver, zinc, and lead properties. More about Coeur Mining

Market Capitalization
$3.90 billion
P/E Ratio
50.93
Consensus Rating
Buy
Consensus Price Target
$8.10 (+33.1% Upside)
Volume
58,522 shares
Average Volume
18.99 million shares
Remove Ads
Denison Mines stock logo

12. Denison Mines NYSEAMERICAN:DNN

$1.32 +0.02 (+1.15%)
As of 09:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mines

Market Capitalization
$1.20 billion
P/E Ratio
-133.50
Consensus Rating
Buy
Consensus Price Target
$3.00 (+126.4% Upside)
Volume
9,590 shares
Average Volume
28.33 million shares
Solid Biosciences stock logo

13. Solid Biosciences NASDAQ:SLDB

$2.77 +0.06 (+2.32%)
As of 09:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Solid Biosciences Inc, a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. More about Solid Biosciences

Market Capitalization
$213.88 million
P/E Ratio
-0.91
Consensus Rating
Buy
Consensus Price Target
$15.67 (+465.0% Upside)
Volume
755 shares
Average Volume
880,725 shares
VNET Group stock logo

14. VNET Group NASDAQ:VNET

$5.59 +0.09 (+1.60%)
As of 09:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

VNET Group, Inc, an investment holding company, provides hosting and related services in China. It offers managed hosting services consisting of managed retail services, such as colocation services that dedicate data center space to house customers' servers and networking equipment, as well as allow customers to lease partial or entire cabinets for their servers; interconnectivity services that allow customers to connect their servers; value-added services, including hybrid IT, bare metal, firewall, server load balancing, data backup and recovery, data center management, server management, and backup server services; cloud services that allow customers to run applications over the internet using IT infrastructure; and VPN Services that extend customers' private networks by setting up connections through the public internet. More about VNET Group

Market Capitalization
$1.45 billion
P/E Ratio
-2.54
Consensus Rating
Buy
Consensus Price Target
$9.30 (+66.4% Upside)
Volume
29,243 shares
Average Volume
3.86 million shares
Uranium Energy stock logo

15. Uranium Energy NYSEAMERICAN:UEC

$4.82 +0.07 (+1.37%)
As of 09:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Uranium Energy Corp., together with its subsidiaries, engages in exploration, pre-extraction, extraction, and processing uranium and titanium concentrates in the United States, Canada, and Paraguay. More about Uranium Energy

Market Capitalization
$2.05 billion
P/E Ratio
-40.38
Consensus Rating
Buy
Consensus Price Target
$10.60 (+120.1% Upside)
Volume
36,386 shares
Average Volume
7.63 million shares
Bioceres Crop Solutions stock logo

16. Bioceres Crop Solutions NASDAQ:BIOX

$4.49 +0.13 (+2.98%)
As of 09:42 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. More about Bioceres Crop Solutions

Market Capitalization
$287.47 million
P/E Ratio
229.31
Consensus Rating
Buy
Consensus Price Target
$9.88 (+119.9% Upside)
Volume
89,810 shares
Average Volume
165,025 shares
Remove Ads
Trevi Therapeutics stock logo

17. Trevi Therapeutics NASDAQ:TRVI

$5.98 +0.42 (+7.63%)
As of 09:44 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Trevi Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC) conditions targeting the central and peripheral nervous systems. More about Trevi Therapeutics

Market Capitalization
$580.00 million
P/E Ratio
-13.63
Consensus Rating
Buy
Consensus Price Target
$17.56 (+193.5% Upside)
Volume
1.19 million shares
Average Volume
1.08 million shares
GeoVax Labs stock logo

18. GeoVax Labs NASDAQ:GOVX

$0.75 -0.32 (-30.00%)
As of 09:09 AM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$10.37 million
P/E Ratio
-0.13
Consensus Rating
Buy
Consensus Price Target
$12.90 (+1,622.3% Upside)
Volume
272,150 shares
Average Volume
588,489 shares
Reviva Pharmaceuticals stock logo

19. Reviva Pharmaceuticals NASDAQ:RVPH

$0.78 +0.01 (+0.89%)
As of 09:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$36.41 million
P/E Ratio
-0.70
Consensus Rating
Buy
Consensus Price Target
$10.00 (+1,177.1% Upside)
Volume
4,762 shares
Average Volume
1.11 million shares
Cardiol Therapeutics stock logo

20. Cardiol Therapeutics NASDAQ:CRDL

$1.00 -0.03 (-3.01%)
As of 09:37 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol Therapeutics

Market Capitalization
$82.53 million
P/E Ratio
-2.56
Consensus Rating
Buy
Consensus Price Target
$8.40 (+740.8% Upside)
Volume
3,010 shares
Average Volume
246,266 shares
Quince Therapeutics stock logo

21. Quince Therapeutics NASDAQ:QNCX

$1.00 0.00 (0.00%)
As of 09:35 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$44.00 million
P/E Ratio
-0.81
Consensus Rating
Buy
Consensus Price Target
$8.00 (+700.0% Upside)
Volume
68,358 shares
Average Volume
246,612 shares
Astria Therapeutics stock logo

22. Astria Therapeutics NASDAQ:ATXS

$4.24 +0.20 (+4.98%)
As of 09:44 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Astria Therapeutics, Inc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. More about Astria Therapeutics

Market Capitalization
$244.08 million
P/E Ratio
-2.07
Consensus Rating
Buy
Consensus Price Target
$26.60 (+527.2% Upside)
Volume
334,040 shares
Average Volume
385,682 shares
Immunic stock logo

23. Immunic NASDAQ:IMUX

$0.93 +0.01 (+1.51%)
As of 09:42 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$84.02 million
P/E Ratio
-0.76
Consensus Rating
Buy
Consensus Price Target
$13.20 (+1,316.3% Upside)
Volume
2,082 shares
Average Volume
831,969 shares
Full House Resorts stock logo

24. Full House Resorts NASDAQ:FLL

$3.06 +0.02 (+0.53%)
As of 09:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Full House Resorts, Inc owns, leases, operates, develops, manages, and invests in casinos, and related hospitality and entertainment facilities in the United States. More about Full House Resorts

Market Capitalization
$110.09 million
P/E Ratio
-2.59
Consensus Rating
Buy
Consensus Price Target
$6.33 (+107.2% Upside)
Volume
1,322 shares
Average Volume
130,363 shares
Mereo BioPharma Group stock logo

25. Mereo BioPharma Group NASDAQ:MREO

$1.94 -0.02 (-0.77%)
As of 09:44 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$300.98 million
P/E Ratio
-32.33
Consensus Rating
Buy
Consensus Price Target
$7.71 (+298.7% Upside)
Volume
1.96 million shares
Average Volume
1.05 million shares